For the TGFβ/Smad pathway, smad4, smad7 and TGFβ are targeted by miR-182-5p [77], miR-93 [87] and miR-21 [37] in bladder cancer, CRC, and colon cancer respectively. This evidence concerns the gene TGFB1 and urinary bladder carcinoma.